Published January 18, 2013 by Bloomberg RESEARCH TRIANGLE PARK, N.C. —GlaxoSmithKline’s settlement of Avandia drug cases triggered a challenge by nine law firms who object to a bid by lead attorneys for almost three-quarters of a $143 million fee fund, including one seeking about $2,700 per hour, according to two people familiar with the matter. […]
The post Dispute Over Attorneys Fees, GlaxoSmithKline Avandia Lawsuit Settlements appeared first on .